drugset

drugset / Trial / NCT00170573

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

NCT00170573 ↗

Phase 2 Completed 77 enrolled North Eastern German Society of Gynaecological Oncology

NaSingle-groupOpen-labelTreatment

Summary

Effect of biweekly schedule of PLD on dose-limiting toxicity of PPE and patient's quality of life

Timeline

Start: 2001-09
Primary completion: 2009-04
Completion: 2010-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Doxorubicin	Other / unclassified	40 mg/m2	—

Indications